ScholarIQanswers from OpenAlex & ORCID
J. Han van Krieken
ResearcherPublications, citations & collaboration network
J. Han van Krieken is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does J. Han van Krieken have?
ScholarIQindexed works
J. Han van Krieken has 687 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does J. Han van Krieken have?
ScholarIQcitation count
J. Han van Krieken has 47,201 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of J. Han van Krieken?
ScholarIQh-index
J. Han van Krieken has an h-index of 92 in OpenAlex.
What is the i10-index of J. Han van Krieken?
ScholarIQi10-index
J. Han van Krieken has an i10-index of 369 in OpenAlex.
What is the ORCID of J. Han van Krieken?
ScholarIQorcid
The ORCID for J. Han van Krieken is on the source record.
What is the OpenAlex record for J. Han van Krieken?
ScholarIQopenalex
The OpenAlex for J. Han van Krieken is on the source record.
What are the most-cited papers on J. Han van Krieken?
ScholarIQmost cited works
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, Hein Putter, Willem H. Steup, Theo Wiggers, H.J.T. Rutten, Lars Påhlman, Bengt Glimelius, J. Han van Krieken, J.W.H. Leer, Cornelis J.�H. van de Velde
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov, Tina Green, Lin Wu, Aarthi Balasubramanyam, Wei-min Liu, Carlo Visco, Yong Li, Roberto N. Miranda, Santiago Montes‐Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Z. Ai, Maurilio Ponzoni, Andrés J.M. Ferreri, Fan Zhou, Graham W. Slack, Randy D. Gascoyne, Meifeng Tu, Daina Variakojis, Weina Chen, Ronald S. Go, Miguel Á. Piris, Michael Møller, L. Jeffrey Medeiros, Ken H. Young
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
H.H. Hartgrink, Cornelis J.�H. van de Velde, Hein Putter, Ilfet Songun, Margot Tesselaar, Elma Meershoek‐Klein Kranenbarg, J.E. de Vries, J. Wils, Jaap van der Bijl, J. Han van Krieken